Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Jones

Showing results (441-450 of 490) with videos related to

Pageof 49
Sort By:
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Schizophrenia Bulletin Open|September 27, 2021
Development and Validation of a Nonremission Risk Prediction Model in First-Episode Psychosis: An Analysis of 2 Longitudinal StudiesSamuel P Leighton, Rajeev Krishnadas, Rachel Upthegrove, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samplesCushla McKinney, Manuela Fanciulli, Marilyn E Merriman, et al.
Psychological Medicine|September 22, 2020
The incidence of psychotic disorders among migrants and minority ethnic groups in Europe: findings from the multinational EU-GEI studyFabian Termorshuizen, Els van der Ven, Ilaria Tarricone, et al.
Psychological Medicine|April 29, 2020
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controlsMusa Sami, Diego Quattrone, Laura Ferraro, et al.
Plos One|July 19, 2014
Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medicationJuha Veijola, Joyce Y Guo, Jani S Moilanen, et al.
Bjpsych Open|November 6, 2025
Characterising negative symptoms in schizophrenia: CHANSS study protocolNoham Wolpe, Clàudia Aymerich, Ying Jin, et al.
The Lancet Regional Health. Western Pacific|September 1, 2023
Prevalence, time trends, and correlates of major depressive episode and other psychiatric conditions among young people amid major social unrest and COVID-19 in Hong Kong: a representative epidemiological study from 2019 to 2022Stephanie M Y Wong, Eric Y H Chen, Y N Suen, et al.
JAMA Psychiatry|December 8, 2017
Treated Incidence of Psychotic Disorders in the Multinational EU-GEI StudyHannah E Jongsma, Charlotte Gayer-Anderson, Antonio Lasalvia, et al.
Psychological Medicine|March 4, 2020
Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control studyHannah E Jongsma, Charlotte Gayer-Anderson, Ilaria Tarricone, et al.
Pageof 49

Showing results (441-450 of 490) with videos related to

Sort By:
Pageof 49
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Schizophrenia Bulletin Open|September 27, 2021
Development and Validation of a Nonremission Risk Prediction Model in First-Episode Psychosis: An Analysis of 2 Longitudinal StudiesSamuel P Leighton, Rajeev Krishnadas, Rachel Upthegrove, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samplesCushla McKinney, Manuela Fanciulli, Marilyn E Merriman, et al.
Psychological Medicine|September 22, 2020
The incidence of psychotic disorders among migrants and minority ethnic groups in Europe: findings from the multinational EU-GEI studyFabian Termorshuizen, Els van der Ven, Ilaria Tarricone, et al.
Psychological Medicine|April 29, 2020
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controlsMusa Sami, Diego Quattrone, Laura Ferraro, et al.
Plos One|July 19, 2014
Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medicationJuha Veijola, Joyce Y Guo, Jani S Moilanen, et al.
Bjpsych Open|November 6, 2025
Characterising negative symptoms in schizophrenia: CHANSS study protocolNoham Wolpe, Clàudia Aymerich, Ying Jin, et al.
The Lancet Regional Health. Western Pacific|September 1, 2023
Prevalence, time trends, and correlates of major depressive episode and other psychiatric conditions among young people amid major social unrest and COVID-19 in Hong Kong: a representative epidemiological study from 2019 to 2022Stephanie M Y Wong, Eric Y H Chen, Y N Suen, et al.
JAMA Psychiatry|December 8, 2017
Treated Incidence of Psychotic Disorders in the Multinational EU-GEI StudyHannah E Jongsma, Charlotte Gayer-Anderson, Antonio Lasalvia, et al.
Psychological Medicine|March 4, 2020
Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control studyHannah E Jongsma, Charlotte Gayer-Anderson, Ilaria Tarricone, et al.
Pageof 49